PatternsRadar
Sign in

AAREYDRUGSAarey Drugs & Pharmaceuticals Limited

NSEASM Stage IBand 5%
116.03INR+3.83 (+3.41%)Close · 20 Nov 2026
14 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹329 CrMarket cap
62.9P/E (TTM)
60.7%Delivery

Filings & corporate actions

22 results filed
CSV
Next results · Q3 FY27
Expected 8 Feb 2027 – 14 Feb 2027
Estimate: filed 39–45 days after quarter end, last 5 times
2026
  • 14 NovresultsResults · Q2 FY27 · standalone-3.5%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026+0.9%NSE
  • 7 SeptshareholdingShareholding · 6 Aug 2026+1.6%NSE
  • 14 AugresultsResults · Q1 FY27 · standalone+2.0%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+2.0%NSE
  • 30 MayresultsResults · Q4 FY26 · standalone-0.8%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+4.8%NSE
  • 11 FebresultsResults · Q3 FY26 · standalone+4.4%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025+0.3%NSE

Reaction to results · all yearsrose on day 0 in 8 of 22 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2714 Nov 2026-3.5%——1.2×
Q1 FY2714 Aug 2026+2.0%-6.9%+17.8%2.1×
Q4 FY2630 May 2026-0.8%+2.5%+15.6%0.7×
Q3 FY2611 Feb 2026+4.4%+5.0%-4.1%2.8×
Q2 FY2614 Nov 2025-0.9%-4.4%-30.7%0.6×
Q1 FY2613 Aug 2025+2.0%-2.3%+11.2%1.1×
Q4 FY2531 May 2025-4.3%+1.0%+25.7%0.3×
Q3 FY2514 Feb 2025-4.7%-8.9%-20.9%2.6×
Q2 FY2514 Nov 2024-0.8%-0.6%+4.4%1.4×
Q1 FY2514 Aug 2024+9.7%+3.8%+18.7%4.6×
Q4 FY2431 May 2024-4.7%-5.9%-2.2%2.0×
Q3 FY2414 Feb 2024+3.9%+3.9%-19.4%1.2×
Q2 FY2411 Nov 2023+1.1%-8.5%-13.1%0.2×
Q1 FY2414 Aug 2023-3.8%-4.2%-0.3%0.6×
Q4 FY2331 May 2023+1.4%+4.9%+16.8%2.3×
Q3 FY238 Feb 2023-3.2%-9.3%-18.5%1.7×
Q2 FY2315 Nov 2022-3.1%-6.5%-3.0%1.0×
Q1 FY2313 Aug 2022-4.2%-4.2%+7.5%1.6×
Q4 FY2231 May 2022-0.4%-2.5%-5.8%0.9×
Q3 FY228 Feb 2022-4.2%-11.9%-16.1%0.6×
Q2 FY2213 Nov 2021+1.0%-2.9%+8.9%1.3×
Q1 FY2211 Aug 2021-1.0%-5.1%-6.6%—
Average-0.6%-3.0%-0.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+5.3%
Profit YoY+33.8%
Interest cost YoY-2.5%
Revenue QoQ+98.6%
Profit QoQ+33.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue-10.1%+8.4%-2.0%———
Profit-6.7%+15.9%-1.3%———

Key data

Open114.78
Day range113.11 – 116.90
52-week range50.31 – 116.90
From 52w high-0.7%
RSI (14)61.3
ATR (14)5.23
Volume2.58L
Avg volume (20D)2.23L
Rel volume1.16×
Volatility (1Y)52.0%
Turnover₹3.0Cr
Traded value (NSE)₹3.0Cr
VWAP115.56
SMA 50 / 200106.15 / 85.45
Price band5%

Delivery percentage

Latest · 20 Nov 202660.7%
20-day avg67.1%
1-year avg77.2%
Percentile (own history)28th
Range20.7–100.0%
Sessions1,308

Over the last 20 sessions AAREYDRUGS settled 67.1% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 77.2%, so recent sessions are running 10.1 points lower than usual. The latest session ranks higher than 28% of the 1,308 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders13.5K · +0.0% QoQ
Net bulk deals, 30D-0.12%
Block deals, 30D₹0
Last bulk buy3 days ago

Performance returns

1D1W1M3M6M1Y
Price+3.41%+0.76%+5.09%+43.98%+41.45%+20.86%

Valuation

Market cap₹329 Cr
Market cap (NSE)₹329 Cr
Free-float cap₹193 Cr
P/E (TTM)62.9
P/E (NSE)70.4
EPS (TTM)1.84
P/B1.9
Net margin (TTM)1.2%
Other income / PBT161.8%
ROE3.3%
Debt / equity0.33
Shares outstanding3.20Cr
Listed6 Aug 2021

Ownership

Promoter41.45%
Promoter Δ QoQ-1.34 pp
Public58.55%
FII4.27%
DII1.44%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)96.4189.544.688.6
YoY chg-27.9%+75.3%-56.3%+5.3%
Net profit (₹ Cr)1.31.61.01.4
YoY chg+78.0%+231.3%-25.4%+33.8%
Net margin1.3%0.8%2.3%1.5%
EPS0.200.550.360.43

Shareholding over time

By quarter

30 Sept 2026 · promoter 41.45% · public 58.55%
30 Sept 2021: promoter 49.38%25 Nov 2021: promoter 48.05%31 Dec 2021: promoter 48.05%31 Mar 2022: promoter 48.06%30 Jun 2022: promoter 50.03%30 Sept 2022: promoter 50.03%31 Dec 2022: promoter 50.03%31 Mar 2023: promoter 50.04%30 Jun 2023: promoter 50.04%30 Sept 2023: promoter 50.04%31 Dec 2023: promoter 50.04%27 Mar 2024: promoter 45.28%31 Mar 2024: promoter 45.28%30 Jun 2024: promoter 45.28%30 Sept 2024: promoter 45.44%31 Dec 2024: promoter 44.80%31 Mar 2025: promoter 44.80%30 Jun 2025: promoter 44.80%30 Sept 2025: promoter 44.80%31 Dec 2025: promoter 39.06%31 Mar 2026: promoter 37.71%30 Jun 2026: promoter 37.71%6 Aug 2026: promoter 42.79%30 Sept 2026: promoter 41.45%
2021-092026-09
  • Promoter
  • Public and others
Promoter
41.45%
Public
58.55%
Promoter change
-1.34 pp
Filed
19 Oct 2026
FII
4.27%
DII
1.44%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
4.28%

-0.13 pp QoQ

Retail ≤ ₹2L
13.83%

-0.45 pp QoQ

HNI > ₹2L
26.37%

+2.38 pp QoQ

NRI
0.31%

-0.01 pp QoQ

Bodies corporate
9.06%

-0.29 pp QoQ

Shareholders
13,485

+0.0% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Bina Rajesh GhataliaPromoter · Individual14.13%
Mihir Rajesh GhataliaPromoter · Individual9.98%
Nimit ImpexPromoter · Corporate6.31%
Nimit Rajesh GhataliaPromoter · Individual5.18%
Mira Mihir GhataliaPromoter · Individual2.95%
Elysian Wealth FundFPI2.78%
Ekta Nimit GhataliaPromoter · Individual1.57%
Krishnamurthy C GIndividual1.57%
Suvi Rubber Pvt LtdCorporate1.47%
Shree Salasar Properties And Finance Private LimitedBank / FI1.44%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
6
0 open-market of the newest 6
By year

No open-market insider trades among the recent disclosures.

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 17 Nov 2026

CSV
12 of 42 deals
By year
DateDealClientQuantityPriceValue
17 Nov 2026Sell · bulkL7 HITECH PRIVATE LIMITED2.56L105.68₹2.7Cr
17 Nov 2026Buy · bulkSHREE SALASAR PROPERTIES & FIN.(P)LTD.2.00L105.57₹2.1Cr
17 Nov 2026Buy · bulkL7 HITECH PRIVATE LIMITED20.5K106.65₹21.9L
7 Oct 2026Buy · bulkVAYUMIND INNOVATIONS PRIVATE LIMITED1.81L109.00₹2.0Cr
7 Oct 2026Sell · bulkAMZEN FINANCIAL SERVICES PRIVATE LIMITED1.81L109.00₹2.0Cr
30 Sept 2026Buy · bulkARYA RAVI MANIRAM1.44L100.01₹1.4Cr
28 Aug 2026Buy · bulkVAYUMIND INNOVATIONS PRIVATE LIMITED2.74L88.97₹2.4Cr
26 Aug 2026Buy · bulkVAYUMIND INNOVATIONS PRIVATE LIMITED1.54L80.45₹1.2Cr
4 Aug 2026Buy · bulkSHREE SALASAR PROPERTIES & FIN.(P)LTD.2.00L84.00₹1.7Cr
17 Apr 2026Buy · bulkSHAH SANJAY JAYKANT1.50L81.51₹1.2Cr
17 Feb 2026Sell · bulkINARAA FINANCIAL SERVICES PRIVATE LIMITED1.43L66.95₹95.7L
12 Feb 2026Sell · bulkNISHITH ATULBHAI SHAH2.58L70.54₹1.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 22 Sept 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.
  • P/E > 50 (4 quarters) · since 18 Jun 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 5% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations76.5210.4126.9105.1133.8108.1102.284.296.4189.544.688.6
Other income0.35.11.60.00.77.51.60.84.2(0.4)1.71.6
Total income76.8215.5128.5105.2134.5115.6103.885.0100.6189.046.390.2
Total expenses75.3213.3127.2103.4133.1114.0102.083.599.7187.845.888.6
└ Finance costs1.11.21.01.50.92.51.01.30.91.81.71.2
└ Depreciation0.50.40.50.50.6(1.4)0.50.70.80.80.90.9
Profit before tax1.52.11.31.71.41.61.71.50.91.30.51.7
Tax expense0.4(0.0)0.10.10.71.20.40.5(0.4)(0.3)(0.5)0.3
Net profit1.02.21.21.60.70.51.41.01.31.61.01.4
EPS0.400.770.881.140.260.040.480.720.200.550.360.43
Net margin1.34%1.02%0.98%1.52%0.54%0.43%1.34%1.22%1.33%0.82%2.29%1.55%
PBT margin1.92%1.02%1.05%1.66%1.05%1.50%1.69%1.76%0.96%0.68%1.16%1.87%
Tax rate30.22%-0.27%6.90%8.58%48.70%71.07%20.65%30.92%-38.34%-21.66%-98.55%17.44%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 14 Nov 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets291.3234.0305.0274.5238.3294.0297.2314.6
Current assets270.6211.798.1251.3213.3256.4262.9283.1
└ Cash & equivalents0.71.21.61.51.57.21.41.4
└ Other bank balances0.00.00.00.00.00.00.00.0
└ Current investments0.0109.50.00.00.00.00.00.0
└ Trade receivables189.80.00.0142.4129.6122.3129.7136.3
└ Inventories28.822.434.729.845.539.141.545.1
Total equity117.4118.9132.8135.6138.5148.9150.4169.7
└ Attributable to owners117.4118.9132.8135.6138.5148.9150.4169.7
└ Share capital25.425.428.128.128.128.528.532.0
Borrowings37.737.431.438.734.950.850.056.3
└ Current33.433.628.10.032.949.549.055.6
└ Non-current4.43.83.238.72.01.31.00.7
Trade payables127.361.1128.90.054.182.981.668.1
Current liabilities168.1109.9168.20.596.9142.9145.1144.2
Total liabilities173.9115.1172.2138.999.8145.1146.8144.9
Net debt37.0(73.3)29.837.233.443.648.654.9
Debt / equity0.320.310.240.290.250.340.330.33
Current ratio1.611.930.58502.702.201.791.811.96

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow(39.1)25.07.92.69.714.610.1(14.8)
└ Capex(1.0)(0.1)0.0(1.0)0.0(10.0)(12.4)(0.2)
Free cash flow(40.1)24.97.91.69.74.5(2.3)(15.0)
Investing cash flow11.120.4(7.3)8.0(5.9)(10.0)(12.4)0.2
Financing cash flow(22.5)(0.3)4.113.7(3.8)1.22.214.6
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(50.5)46.34.724.2(0.1)5.7(0.1)(0.0)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

AAREYDRUGS at a glance

  • AAREYDRUGS closed at ₹116.03 on 20 Nov 2026, +3.41% on the day, +20.9% over one year, 0.7% below its 52-week high of ₹116.9.
  • Delivery was 60.7% of traded quantity on 20 Nov 2026, the 28th percentile of its own 1,308 sessions with a reading (20-session average 67.1%, 1-year average 77.2%).
  • Market capitalisation is ₹329 crore at a trailing P/E of 62.9 (trailing EPS ₹1.84).
  • Q2 FY27 results (standalone, filed 14 Nov 2026): revenue ₹89 crore (+5.3% year on year), net profit ₹1 crore (+33.8%); the price moved -3.5% on the first session after.
  • Promoters held 41.45% at 30 Sept 2026, down 1.34 percentage points on the previous filing.
  • Q3 FY27 results are expected between 8 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE198H01019
SeriesEQ
Listed6 Aug 2021
NSE market cap · 17 Nov 2026₹306 Cr
Free-float market cap (NSE)₹171 Cr
Shares outstanding (NSE)2.84Cr
History from6 Aug 2021
Sessions1,312

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.